References
- Arnold E. S., Rudd S. M., Kirshner H. Manic psychosis following rapid withdrawal of baclofen. American Journal of Psychiatry 1980; 137: 1466–1467
- Avery G. S. Drug treatment, 2nd Ed. Adis Press, Sydney 1980
- Bowery N. G., Hill D. R., Hudson A. L., Doble A., Middlemiss D. N., Shaw J., Turnbull M. Baclofen decreases neurotransmitter release in the mammalian CNS by an action at a novel GABA receptor. Nature 1980; 283: 92–94
- Brown D. A., Higgins A. J. Presynaptic effects of γ‐aminobutyric acid in isolated rat superior cervical ganglia. British Journal of Pharmacology 1979; 66: 108P–109P
- Carlsson A. Antipsychotic drugs, neurotransmitters and schizophrenia. American Journal of Psychiatry 1978; 135: 164–173
- Creese I., Sibley D. R. Receptor adaptations to centrally acting drugs. Annual Review of Pharmacology and Toxicology 1981; 21: 357–391
- Kaariainen I. Effects of aminooxyacetic acid and baclofen on the catalepsy and on the increase of mesolimbic and striatal dopamine turnover induced by haloperidol in rats. Acta Pharmacologica et Toxicologica 1976; 39: 393–400
- Korsgaard S. Baclofen (Lioresal) in the treatment of neuroleptic induced tardive dyskinesia. Acta Psychiatrica Scandinavia 1976; 54: 17–24
- Lees A. J., Clarke C. R., Harrison M. J. Hallucinations after withdrawal of baclofen. Lancet 1977; 1: 858
- Nelson J. C., Charney D. S. The symptoms of depressive illness. American Journal of Psychiatry 1981; 138: 1–13
- Richardson J. S., Lamprecht F., Kazic T., Kopin I. J. Reduction in brain tyrosine hydroxylase activity following acstylcholinssterass blockade in rats. Canadian Journal of Physiology and Pharmacology 1976; 54: 774–778
- Richardson J. S., Richardson A. K. The biphasic dose‐response effect of baclofen on haloperidol catalepsy in the rat. Pharmacology, Biochemistry and Behavior 1982; 17: 855–856
- Skaung O. B., Korsgaard S. Hallucinations and baclofen. Lancet 1977; 1: 1258
- Stien R. Hallucinations after sudden withdrawal of baclofen. Lancet 1977; 2: 44–45
- Sulser F. New perspectives on the mode of action of antidepressant drugs. Trends in Pharmacological Sciences 1979; 1: 92–96
- Sweeney D., Nelson C., Bowers M. L., Maas J., Heninger G. Delusional versus nondelusional depression; neurochemical differences. Lancet 1978; 2: 100–101
- Van Praag H. M., Karf J., Lakke J. P. W. F., Schut T. Dopamine metabolism in depression, psychoses, and Parkinson's Disease: The problem of specificity of biological variables in behavioral disorders. Psychological Medicine 1975; 5: 138–146
- Waddington J. L., Cross A. L. Pharmacology of (+) and (—) baclofen: GABA‐dependent rotational behaviour and (3H)‐GABA receptor binding studies. Neuroscience Letters 1979; 14: 123–127
- Worms P., Lloyd K. G. Biphasic effect of direct but not indirect GABA mimetics and antagonists on haloperidol‐induced catalepsy. Naunyn‐Schmiedeberg's Archives of Pharmacology 1980; 311: 179–184